Dr. Jeffrey David Karduck, MD

Dr. Karduck practices at University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa.

Dr. Karduck's NPI, 1124480454, was assigned on March 25, 2016. Dr. Karduck holds Iowa license MD-49651.

Dr. Karduck's primary practice is University of Iowa Health Care Medical Center, at 200 Hawkins Drive, Iowa City, IA 52242 in Johnson County. The practice phone is (319) 356-1616.

Dr. Karduck's primary practice is University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa. Dr. Karduck is also affiliated with University of Iowa Health Care Medical Center Downtown. The medical group on file is Scanlan Center for School Mental Health Clinic. Dmand AI also links Dr. Karduck to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karduck practices, 4 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Karduck's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Karduck is licensed in Iowa.

CMS data shows 542 Medicare services from Dr. Karduck across 8 procedure codes in 2024, for 214 Medicare patients. Medicare paid $36,134 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 214 Medicare patients who saw Dr. Karduck in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Karduck's median patient age at 69, with 52% women.

In 2024, Dr. Karduck wrote 974 Medicare Part D claims for 111 patients. 76% of them were for generic drugs. CMS names the drug for 903 of them, across 20 drugs with 11 or more claims each, at $275,112 in total drug cost. In 2023, CMS named 528 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Karduck for performance year 2024, reported through an alternative payment model (APM). Dr. Karduck accepts Medicare assignment, so Medicare's approved amount is taken as full payment.